Nuvation Bio Inc. financial data

Symbol
NUVB, NUVB-WT on NYSE
Location
357 Tehama Street, Floor 3, San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 926 % -63.1%
Debt-to-equity 28 % +394%
Return On Equity -46.1 % +53.3%
Return On Assets -36 % +56.6%
Operating Margin -1.56K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 342M shares +37.3%
Common Stock, Shares, Outstanding 338M shares +35.9%
Entity Public Float 523B USD +100%
Common Stock, Value, Issued 1.4B USD +29.5%
Weighted Average Number of Shares Outstanding, Basic 341K shares +39.2%
Weighted Average Number of Shares Outstanding, Diluted 341K shares +39.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 4.83M USD +237%
Revenue from Contract with Customer, Excluding Assessed Tax 14.4M USD +237%
Research and Development Expense 109M USD +43.4%
General and Administrative Expense 28.2M USD -12.5%
Operating Income (Loss) -225M USD +58.2%
Nonoperating Income (Expense) 21.7M USD -19.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -203M USD +60.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -203M USD +60.3%
Earnings Per Share, Basic 0 USD/shares +77.4%
Earnings Per Share, Diluted 0 USD/shares +77.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 248M USD +623%
Marketable Securities, Current 360M USD -33.7%
Inventory, Net 552K USD
Assets, Current 623M USD +6.14%
Property, Plant and Equipment, Net 615K USD -18.1%
Operating Lease, Right-of-Use Asset 4.64M USD +70.4%
Other Assets, Noncurrent 6.62M USD +515%
Assets 647M USD +8.82%
Accounts Payable, Current 22.4M USD +330%
Accrued Liabilities, Current 24M USD +20.1%
Contract with Customer, Liability, Current 9.73M USD -20.3%
Liabilities, Current 66.4M USD +29.9%
Contract with Customer, Liability, Noncurrent 13.6M USD
Accrued Income Taxes, Noncurrent 679K USD +372%
Operating Lease, Liability, Noncurrent 3.4M USD +250%
Liabilities 274M USD +338%
Common Stocks, Including Additional Paid in Capital 117M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -327K USD +74.2%
Retained Earnings (Accumulated Deficit) -1.02B USD -24.7%
Stockholders' Equity Attributable to Parent 373M USD +45%
Liabilities and Equity 647M USD +8.82%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -42.6M USD -171%
Net Cash Provided by (Used in) Financing Activities 548K USD +2510%
Net Cash Provided by (Used in) Investing Activities 54.2M USD +618%
Common Stock, Shares Authorized 1.06B shares
Common Stock, Shares, Issued 342M shares +37.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12.3M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 248M USD +623%
Deferred Tax Assets, Valuation Allowance 238M USD +137%
Deferred Tax Assets, Gross 243M USD +139%
Operating Lease, Liability 5.21M USD +70.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -202M USD +60.2%
Lessee, Operating Lease, Liability, to be Paid 5.97M USD +85.3%
Property, Plant and Equipment, Gross 1.46M USD +5.57%
Operating Lease, Liability, Current 1.81M USD -12.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.13M USD +50.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.08M USD -1.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +29.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 760K USD +339%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.38M USD +119%
Deferred Tax Assets, Operating Loss Carryforwards 108M USD +268%
Unrecognized Tax Benefits 7.39M USD +31.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.22M USD +1401%
Share-based Payment Arrangement, Expense 37.6M USD +58%
Interest Expense 266K USD +102%